Central XXXX and @entity9998 .

@entity1 @entity101 @entity63 @entity2994 @entity9998 @entity726
PURPOSE: The purpose of this study was to investigate the existence of @entity9998 ( @entity9998 ) as a risk factor for the development of @entity2994 ( @entity2994 ). METHODS: This was a retrospective, comparative study of the prevalence of pseudoexfoliation in three groups of @entity1 : 48 @entity1 with @entity2994 , 164 @entity1 with @entity2994 ( @entity2994 ), and 70 control @entity1 (70 eyes). All @entity1 were phakic and had no previous diagnosis of @entity726 . @entity1 were matched in terms of age and systemic @entity101 . All @entity1 had normal intraocular pressure (IOP) at presentation (defined as less than or equal to 21 mmHg). RESULTS: In the @entity2994 group, 14 out of 48 @entity1 were diagnosed as having @entity9998 (29.17%). In the @entity2994 group, 14 out of 164 @entity1 had @entity9998 (8.5%), and in the control group, six out of 70 @entity1 had @entity9998 (8.6%). Differences of percentage between groups were statistically significant (P<0.001,    (2) test). When comparing @entity1 subgroup with @entity63 @entity2994 with subgroup with non- @entity63 @entity2994 , we found that in the @entity63 @entity2994 group, 13 out of 27 @entity1 were diagnosed as having @entity9998 (48.15%), and in the non- @entity63 @entity2994 group, one out of 21 @entity1 was diagnosed as having @entity9998 (4.7%; P<0.001,    (2) test). The relative odds of having @entity2994 in @entity1 with @entity9998 versus @entity1 without @entity9998 were 4.406 (confidence interval [CI], 2.03-9.54). CONCLUSION: @entity9998 and @entity2994 , especially @entity63 , are strongly associated in our study. Our results indicate that @entity9998 might be an independent factor for @entity2994 , as it is related with @entity2994 independently from @entity726 .
